文献速递主动脉疾病

局部区域麻醉在破裂腹主动脉瘤腔内修复术后结局更优

Locoregional Anesthesia Offers Improved Outcomes after Endovascular Repair of Ruptured Abdominal Aortic Aneurysms.
PubMed 文献 · Ann Vasc Surg · 2019-02-22

LA组30天死亡率显著低于GA组(16.3% vs. 25.2%,P<0.01),在血流动力学不稳定亚组差异更明显(15.4% vs. 39.4%,P<0.01),且ICU住院更短、肺炎率更低。调整混杂后GA组死亡风险为LA组两倍,不稳定患者达四倍。

要点

  • REVAR中仅12.5%使用LA,血流动力学不稳定者中比例亦未改变。
  • LA组30天死亡率显著低于GA组,不稳定亚组差异更显著。
  • LA组ICU住院更短、肺炎率更低,应考虑用于REVAR患者。

核心结论

  • LA用于REVAR与更低的30天死亡率、更短ICU住院和更低肺炎率相关。
  • 调整混杂后GA组死亡风险为LA组两倍,血流动力学不稳定者达四倍。
  • 数据提示REVAR患者无论血流动力学是否稳定均应考虑LA。

研究设计与样本

  • 回顾性队列研究,使用ACS NSQIP靶向EVAR数据库2011年1月至2015年12月数据。
  • 采用单变量和多变量分析比较两组术前人口学、手术变量和30天结局。

主要发现

  • 全队列平均年龄74.3岁,80%为男性,平均动脉瘤直径7.6 cm,两组间无差异。
  • LA组双侧经皮入路比例更高(59.3% vs. 25.2%,P<0.01)。
  • LA组平均手术时间更短(132 vs. 166 min,P<0.01),同期下肢血运重建率更低(2.3% vs. 10.6%,P<0.01)。
  • LA组30天死亡率显著更低(16.3% vs. 25.2%,P<0.01),血流动力学不稳定亚组差异更明显(15.4% vs. 39.4%,P<0.01)。
  • LA组ICU住院更短(3.0 vs. 5.0天,P=0.01),术后肺炎率更低(3.5% vs. 10.9%,P=0.03)。

关键数值与推荐

  • LA组充血性心力衰竭比例略高于GA组(7.0% vs. 2.5%,P=0.02)。
  • 两组围手术期输血需求及其他辅助操作无差异。
  • 调整人口学、合并症、低血压状态和动脉瘤特征后,GA组死亡风险为LA组两倍,不稳定队列为四倍。

临床怎么用

  • REVAR患者可考虑优先选择LA,尤其血流动力学不稳定者。
  • LA可能缩短ICU住院并降低术后肺炎风险。
  • 当前全国性队列中LA使用率仅12.5%,存在推广空间。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: General anesthesia (GA) and locoregional anesthesia (LA) are two anesthetic options for endovascular repair of ruptured abdominal aortic aneurysms (REVAR). Studies on elective endovascular repair of nonruptured aneurysms have indicated that in select patients, LA may provide improved outcomes compared with GA. We aimed to examine the 30-day outcomes in patients undergoing REVAR using GA and LA in a contemporary nationwide cohort of patients presenting with ruptured abdominal aortic aneurysms. METHODS: Patients who underwent REVAR using GA and LA from January 2011 through December 2015, inclusively, were studied in the American College of Surgeons' National Surgical Quality Improvement Program (ACS NSQIP)-targeted EVAR database. Univariate and multivariate analyses were used to compare preoperative demographics, operation-specific variables, and 30-day postoperative outcomes between the two groups. RESULTS: Six-hundred ninety patients were identified to have undergone REVAR from 2011 to 2015, of which 12.5% (86) were performed under LA. For the entire cohort, the mean age was 74.3 years, and 80% were male. Mean aneurysm size was 7.6 cm and did not differ between the two anesthetic groups. Major comorbidities were similar between both groups, except a slightly higher rate of congestive heart failure in the LA group (7.0% vs. 2.5%, P = 0.02). Proximal or distal aneurysm extent also did not differ between the two groups. There was a significantly higher rate of bilateral percutaneous access in the LA group (59.3% vs. 25.2%, P < 0.01). REVAR under LA had shorter mean operative time (132 vs. 166 min, P < 0.01) and lower rate of concomitant lower extremity revascularization (2.3% vs. 10.6%, P < 0.01). There were no differences in need for perioperative transfusion or any other adjunctive procedures. Ultimately, 30-day mortality was significantly lower in the LA group (16.3% vs. 25.2%, P < 0.01). This difference was more pronounced in the subgroup of patients with hemodynamic instability (15.4% vs. 39.4%, P < 0.01). The LA group also demonstrated significantly shorter intensive care unit (ICU) length of stay (3.0 vs. 5.0 days, P = 0.01) and low rates of postoperative pneumonia (3.5% vs. 10.9%, P = 0.03). After adjustment for demographics, comorbid conditions, hypotensive status, and aneurysm characteristics, there was a two-fold higher mortality in patients undergoing REVAR using GA versus LA, with a four-fold increase in the hemodynamically unstable cohort. CONCLUSIONS: The ACS NSQIP-targeted EVAR database shows that LA is used in only 12.5% of patients undergoing REVAR in this nationwide cohort. This rate does not change when examining the subset of patients who are hemodynamically unstable. Other benefits include shorter ICU lengths of stay and lower rates of pneumonia. These data suggest that LA should be considered in patients undergoing REVAR, regardless of hemodynamic instability.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chen SL, Kabutey NK, Whealon MD, et al. Locoregional Anesthesia Offers Improved Outcomes after Endovascular Repair of Ruptured Abdominal Aortic Aneurysms. Ann Vasc Surg. 2019. PMID: 30802568. doi:10.1016/j.avsg.2018.12.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。